1
|
Hong Q, Wang YP, Zhang M, et al: Homer
expression in the hippocampus of an animal model of
attention-deficit/hyperactivity disorder. Mol Med Report.
4:705–712. 2011.PubMed/NCBI
|
2
|
Genro JP, Kieling C, Rohde LA and Hutz MH:
Attention-deficit/hyperactivity disorder and the dopaminergic
hypotheses. Expert Rev Neurother. 10:587–601. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Elia J and Devoto M: ADHD genetics: 2007
update. Curr Psychiatry Rep. 9:434–439. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Sharp SI, Mcquillin A and Gurling HM:
Genetics of attention-deficit hyperactive disorder (ADHD).
Neuropharmacology. 57:590–600. 2009. View Article : Google Scholar
|
5
|
Gizer IR, Ficks C and Waldman ID:
Candidate gene studies of ADHD: a meta-analytic review. Hum Genet.
126:51–90. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kolesnichenko LS, Kulinskiĭ VI and Gorina
AS: Amino acids and their metabolites in blood and urine of
children with minimal cerebral dysfunction. Vopr Med Khim.
45:58–64. 1999.(In Russian).
|
7
|
Miyazaki M, Ito H, Saijo T, et al:
Favorable response of ADHD with giant SEP to extended-release
valproate. Brain Dev. 28:470–472. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Powell SG, Thomsen PH, Frydenberg M and
Rasmussen H: Long-term treatment of ADHD with stimulants: a large
observational study of real-life patients. J Atten Disord.
15:439–451. 2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
American Psychiatric Association (APA).
Diagnostic and statistical manual of mental disorders. 4th ed.
American Psychiatric Press; Washington DC: 1994
|
10
|
Li J, Kang C, Zhang H, et al: Monoamine
oxidase A gene polymorphism predicts adolescent outcome of
attention-deficit/hyperactivity disorder. Am J Med Genet B.
144B:430–433. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Barnard-Brak L, Sulak TN and Fearon DD:
Coexisting disorders and academic achievement among children with
ADHD. J Atten Disord. 15:506–515. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Domschke K, Sheehan K, Lowe N, et al:
Association analysis of the monoamine oxidase A and B genes with
attention deficit hyperactivity disorder (ADHD) in an Irish sample:
preferential transmission of the MAO-A 941G allele to affected
children. Am J Med Genet B Neuropsychiatr Genet. 134B:110–114.
2005. View Article : Google Scholar
|
13
|
DiMaio S, Grizenko N and Joober R:
Dopamine genes and attention-deficit hyperactivity disorder: a
review. J Psychiatry Neurosci. 28:27–38. 2003.PubMed/NCBI
|
14
|
Fisher SE, Francks C, McCracken JT, et al:
A genomewide scan for loci involved in
attention-deficit/hyperactivity disorder. Am J Hum Genet.
70:1183–1196. 2002. View
Article : Google Scholar : PubMed/NCBI
|
15
|
Craig SP, Buckle VJ, Lamouroux A, Mallet J
and Craig IW: Localization of the human dopamine beta hydroxylase
(DBH) gene to chromosome 9q34. Cytogenet Cell Genet. 48:48–50.
1988. View Article : Google Scholar : PubMed/NCBI
|
16
|
Kopecková M, Paclt I, Petrásek J, Pacltová
D, Malíková M and Zagatová V: Some ADHD polymorphisms (in genes
DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects
6–10 age. Neuro Endocrinol Lett. 29:246–251. 2008.PubMed/NCBI
|
17
|
Kieling C, Genro JP, Hutz MH and Rohde LA:
The -1021 C/T DBH polymorphism is associated with
neuropsychological performance among children and adolescents with
ADHD. Am J Med Genet B Neuropsychiatr Genet. 147B:485–490. 2008.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Misener VL, Luca P, Azeke O, et al:
Linkage of the dopamine receptor D1 gene to
attention-deficit/hyperactivity disorder. Mol Psychiatry.
9:500–509. 2004. View Article : Google Scholar : PubMed/NCBI
|
19
|
Bobb AJ, Addington AM, Sidransky E, et al:
Support for association between ADHD and two candidate genes: NET1
and DRD1. Am J Med Genet B Neuropsychiatr Genet. 134B:67–72. 2005.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Balk JH, Picetti R, Saiardi A, et al:
Parkinsonian-like locomotor impairment in mice lacking dopamine D2
receptors. Nature. 377:424–428. 1995. View
Article : Google Scholar : PubMed/NCBI
|
21
|
Grandy DK, Litt M, Allen L, et al: The
human dopamine D2 receptor gene is located on chromosome 11 at q22-
q23 and identifies a TaqI RFLP. Am J Hum Genet. 45:778–785.
1989.PubMed/NCBI
|
22
|
Paclt I, Drtilkova I, Kopeckova M, Theiner
P, Serý O and Cermakova N: The association between TaqI A
polymorphism of ANKK1 (DRD2) gene and ADHD in the Czech boys aged
between 6 and 13 years. Neuro Endocrinol Lett. 31:131–136.
2010.PubMed/NCBI
|
23
|
Serý O, Drtílková I, Theiner P, et al:
Polymorphism of DRD2 gene and ADHD. Neuro Endocrinol Lett.
27:236–240. 2006.PubMed/NCBI
|
24
|
Todd RD and Lobos EA: Mutation screening
of the dopamine D2 receptor gene in attention-deficit hyperactivity
disorder subtypes: preliminary report of a research strategy. Am J
Med Genet. 114:34–41. 2002. View Article : Google Scholar : PubMed/NCBI
|
25
|
Pálmason H, Moser D, Sigmund J, et al:
Attention-deficit/hyperactivity disorder phenotype is influenced by
a functional catechol-O-methyltransferase variant. J Neural Transm.
117:259–267. 2010.PubMed/NCBI
|
26
|
Comings DE: Clinical and molecular
genetics of ADHD and Tourette syndrome. Two related polygenic
disorders. Ann N Y Acad Sci. 931:50–83. 2001. View Article : Google Scholar : PubMed/NCBI
|
27
|
Sagvolden T, Johansen EB, Aase H and
Russell VA: A dynamic developmental theory of
attention-deficit/hyperactivity disorder (ADHD) predominantly
hyperactive/impulsive and combined subtypes. Behav Brain Sci.
28:397–468. 2005. View Article : Google Scholar
|
28
|
Amantea D and Bowery NG: Reduced
inhibitory action of a GABAB receptor agonist on [3H]-dopamine
release from rat ventral tegmental area in vitro after chronic
nicotine administration. BMC Pharmacol. 4:242004.
|
29
|
Hossain MA and Weiner N: Interactions of
dopaminergic and GABAergic neurotransmission: impact of
6-hydroxydopamine lesions into the substantia nigra of rats. J
Pharmacol Exp Ther. 275:237–244. 1995.PubMed/NCBI
|